Molybdenum Disulphide Modified Polylactide for 3D Printed (FDM/FFF) Filaments.

MoS2 is an additive used to improve the tribological properties of plastics. In this work, it was decided to verify the use of MoS2 as a modifier of the properties of PLA filaments used in the additive FDM/FFF technique. For this purpose, MoS2 was introduced into the PLA matrix at concentrations of 0.025-1.0% by weight. Through extrusion, a fibre with a diameter of 1.75 mm was obtained. 3D printed samples with three different filling patterns were subjected to comprehensive thermal (TG, DSC and HDT), mechanical (impact, bending and strength tests), tribological and physicochemical characteristics. The mechanical properties were determined for two different types of fillings, and samples with the third type of filling were used for tribological tests. Tensile strength has been significantly increased for all samples with longitudinal filling with improvement up to 49%. In terms of tribological properties, higher values of the addition (0.5%) caused a significant increase of up to 457% of the wear indicator. A significant improvement in processing properties in terms of rheology was obtained (416% compared to pure PLA with the addition of 1.0%), which translated into more efficient processing, increased interlayer adhesion and mechanical strength. As a result, the quality of printed objects has been improved. Microscopic analysis was also carried out, which confirmed the good dispersion of the modifier in the polymer matrix (SEM-EDS). Microscopic techniques (MO, SEM) allowed for the characterization of the effect of the additive on changes in the printing process (improvement of interlayer remelting) and to assess impact fractures. In the tribological area, the introduced modification did not bring spectacular effects.

Deposition of Biocompatible Polymers by 3D Printing (FDM) on Titanium Alloy.

Nowadays, the replacement of a hip joint is a standard surgical procedure. However, researchers have continuingly been trying to upgrade endoprostheses and make them more similar to natural joints. The use of 3D printing could be helpful in such cases, since 3D-printed elements could mimic the natural lubrication mechanism of the meniscus. In this paper, we propose a method to deposit plastics directly on titanium alloy using 3D printing (FDM). This procedure allows one to obtain endoprostheses that are more similar to natural joints, easier to manufacture and have fewer components. During the research, biocompatible polymers suitable for 3D FDM printing were used, namely polylactide (PLA) and polyamide (PA). The research included tensile and shear tests of metal-polymer bonds, friction coefficient measurements and microscopic observations. The friction coefficient measurements revealed that only PA was promising for endoprostheses (the friction coefficient for PLA was too high). The strength tests and microscopic observations showed that PLA and PA deposition by 3D FDM printing directly on Ti6Al4V titanium alloy is possible; however, the achieved bonding strength and repeatability of the process were unsatisfactory. Nevertheless, the benefits arising from application of this method mean that it is worthwhile to continue working on this issue.

Low-cost, programmable infusion pump with bolus mode for in-vivo imaging.

Syringe pumps are routinely used in biomedical imaging laboratories for delivering contrast agents and either infusing or injecting a precise amount of liquids. Commercial syringe pumps that are developed by specialized companies are expensive and only have standard functions, which often do not meet the requirements of individual experiments. In this paper, we demonstrate an open-source single syringe pump with the possibility of adapting to the needs of a researcher. The device that was designed, is controlled by an Arduino Leonardo, along with the stepper motor driver. For sending commands and receiving the current plunger position, a C# software was developed with serial communication via USB. Additionally, the 3D models were made in a universal way, which allows for the use of any syringe size. An example of the application of the syringe pump for biomedical applications was demonstrated using electron resonance imaging (ERI). The single syringe pump tests were demonstrated by simulating the filling of a particular volume inside the resonator. This example reflects the clearance process after an intravascular (I.V) drug administration in the murine model. The experiments were performed on an ERI TM 600 tomograph. The results confirmed that the designed syringe pump allowed for controlling the infusion speed and injected volume. Moreover, we present a user-friendly and open-source graphical interface that is a low-cost alternative for commercial devices.

Graphite Modified Polylactide (PLA) for 3D Printed (FDM/FFF) Sliding Elements.

With the development of 3D printing technology, there is a need to produce printable materials with improved properties, e.g., sliding properties. In this paper, the authors present the possibilities of producing composites based on biodegradable PLA with the addition of graphite. The team created composites with the following graphite weight contents: 1%, 2.5%, 5%, 7.5%, and 10%. Neat material was also subjected to testing. Tribological, mechanical, and chemical properties of the mentioned materials were examined. Measurements were also made after keeping the samples in ageing and climatic ovens. Furthermore, SEM observations of samples before and after friction tests were carried out. It was demonstrated that increasing graphite content caused a significant decrease in wear (PLA + 10% graphite had a wear rate three times lower than for a neat material). The addition of graphite did not adversely affect most of the other properties, but it ought to be noted that mechanical properties changed significantly. After conditioning in a climatic oven PLA + 10% graphite has (in comparison with neat material) 11% lower fracture stress, 47% lower impact strength, and 21% higher Young's modulus. It can be certainly stated that the addition of graphite to PLA is a step towards obtaining a material that is low-cost and suitable for printing sliding spare parts.

The Influence of Deformation under Tension on Some Mechanical and Tribological Properties of High-Density Polyethylene.

Polymer materials are increasingly being used for sliding machine elements due to their numerous advantages. They are used even where they are deformed and in such a state that they interact frictionally, e.g., in machine hydraulics or lip seals. Few publications deal with the influence of deformation, which is the effect of, e.g., assembly on tribological properties of polymeric material. This deformation can reach up to ε ≈ 20% and is achieved without increasing the temperature of the polymer material. The paper presents the results of investigations in which high-density polyethylene (PE-HD) was maintained in deformation by means of a special grip (holder). The wear of the sample was significantly higher than that of the undeformed sample. This effect persisted even after partial relaxation of the stress in the sample after 24 h. Additional investigations were carried out to explain the obtained results. There were the microscopic observations of the surface after friction, measurements of microhardness, and surface free energy. Changes in the value of surface free energy and a significant decrease in microhardness with deformation under tension were observed. Deformed materials have a different surface appearance after friction and a different size and form of wear products. It was indicated that it is probable that the cohesion of the material will decrease and that the character of the wear process will change as a result of tension. Deformation under tension without heating of polymeric material (PE-HD), e.g., as a result of assembly, has been qualified as a threat to be taken into account when designing and analysing polymeric sliding elements.

Synthesis of amide and sulfonamide substituted N-aryl 6-aminoquinoxalines as PFKFB3 inhibitors with improved physicochemical properties.

In oncology, the "Warburg effect" describes the elevated production of energy by glycolysis in cancer cells. The ubiquitous and hypoxia-induced 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3) plays a noteworthy role in the regulation of glycolysis by producing fructose-2,6-biphosphate (F-2,6-BP), a potent activator of the glycolysis rate-limiting phosphofructokinase PFK-1. Series of amides and sulfonamides derivatives based on a N-aryl 6-aminoquinoxaline scaffold were synthesized and tested for their inhibition of PFKFB3 in vitro in a biochemical assay as well as in HCT116 cells. The carboxamide series displayed satisfactory kinetic solubility and metabolic stability, and within this class, potent lead compounds with low nanomolar activity have been identified with a suitable profile for further in vivo evaluation.

Discovery and Structure-Activity Relationships of N-Aryl 6-Aminoquinoxalines as Potent PFKFB3 Kinase Inhibitors.

Energy and biomass production in cancer cells are largely supported by aerobic glycolysis in what is called the Warburg effect. The process is regulated by key enzymes, among which phosphofructokinase PFK-2 plays a significant role by producing fructose-2,6-biphosphate; the most potent activator of the glycolysis rate-limiting step performed by phosphofructokinase PFK-1. Herein, the synthesis, biological evaluation and structure-activity relationship of novel inhibitors of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3), which is the ubiquitous and hypoxia-induced isoform of PFK-2, are reported. X-ray crystallography and docking were instrumental in the design and optimisation of a series of N-aryl 6-aminoquinoxalines. The most potent representative, N-(4-methanesulfonylpyridin-3-yl)-8-(3-methyl-1-benzothiophen-5-yl)quinoxalin-6-amine, displayed an IC50 of 14 nm for the target and an IC50 of 0.49 µm for fructose-2,6-biphosphate production in human colon carcinoma HCT116 cells. This work provides a new entry in the field of PFKFB3 inhibitors with potential for development in oncology.